Saturday, October 31, 2026

STERIS And 3 Other Stocks Have Very High Payout Ratio

ViaNews Editorial Team

November 16, 2021

STERIS And 3 Other Stocks Have Very High Payout Ratio

(VIANEWS) - Healthcare Services Group (HCSG), STERIS (STE), Nuveenn Intermediate Duration Quality Municipal Term Fund (NIQ) are the highest payout ratio stocks on this list.

We have collected information regarding stocks with the highest payout ratio up to now. The payout ratio in itself isn't a promise of good investment but it's an indicator of whether dividends are being paid and how the company chooses to distribute them.

When investigating a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.

1. Healthcare Services Group (HCSG)

69.12% Payout Ratio

Healthcare Services Group, Inc. provides management, administrative, and operating services to the housekeeping, laundry, linen, facility maintenance, and dietary service departments of nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States.

Volume

Today's last reported volume for Healthcare Services Group is 275873, 75.96% below its average volume of 1147640.

As stated by Morningstar, Inc., the next dividend payment is on Aug 18, 2021, the estimated forward annual dividend rate is 0.83 and the estimated forward annual dividend yield is 3.27%.

Healthcare Services Group's sales growth this year is anticipated to be negative 7.2% and 6.2% for next year.

Year-on-year quarterly revenue growth declined by 11.9%, now sitting on 1.67B for the twelve trailing months.

Healthcare Services Group's sales growth for the next quarter is negative 1.7%. The company's growth estimates for the ongoing quarter and the next is negative 29.7% and negative -27%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.11%.

Volatility

Healthcare Services Group's last day, week, and month's current volatility was 0.52%, 0.97%, and 2.13%, respectively.

Healthcare Services Group's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.88% (day), 3.16% (last week), and 3.59% (last month), respectively.

Healthcare Services Group's Stock Yearly Top and Bottom Value

Healthcare Services Group's stock is valued at $19.38 at 19:23 EST, way below its 52-week high of $35.80 and above its 52-week low of $18.77.

Healthcare Services Group's Moving Average

Healthcare Services Group's value is way below its 50-day moving average of $22.27 and way below its 200-day moving average of $27.19.

2. STERIS (STE)

47.9% Payout Ratio

STERIS plc provides infection prevention and other procedural products and services worldwide.

Volume

Today's last reported volume for STERIS is 287585, 39.99% below its average volume of 479235.

As stated by Morningstar, Inc., the next dividend payment is on Sep 1, 2021, the estimated forward annual dividend rate is 1.72 and the estimated forward annual dividend yield is 0.8%.

STERIS's sales growth this year is expected to be 47.6% and 10.3% for next year.

Year-on-year quarterly revenue growth grew by 44.8%, now sitting on 3.41B for the twelve trailing months.

STERIS's sales growth for the current quarter is 59.3%. The company's growth estimates for the ongoing quarter and the next is 23% and 13.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.67%.

Volatility

STERIS's last day, week, and month's current volatility was 0.01%, 0.39%, and 1.06%, respectively.

STERIS's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.75% (day), 1.76% (last week), and 2.03% (last month), respectively.

STERIS's Stock Yearly Top and Bottom Value

STERIS's stock is valued at $232.38 at 19:23 EST, under its 52-week high of $237.27 and way above its 52-week low of $170.36.

STERIS's Moving Average

STERIS's value is above its 50-day moving average of $222.81 and above its 200-day moving average of $211.77.

3. Nuveenn Intermediate Duration Quality Municipal Term Fund (NIQ)

44.43% Payout Ratio

Nuveen Intermediate Duration Quality Municipal Term Fund is a close ended fixed income mutual fund launched by Nuveen Investments Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC.

Volume

Today's last reported volume for Nuveenn Intermediate Duration Quality Municipal Term Fund is 31979, 63.76% above its average volume of 19527.

As claimed by Morningstar, Inc., the next dividend payment is on Oct 13, 2021, the estimated forward annual dividend rate is 0.51 and the estimated forward annual dividend yield is 3.43%.

Volatility

Nuveenn Intermediate Duration Quality Municipal Term Fund's last day, week, and month's current volatility was 0.13%, 0.45%, and 0.49%, respectively.

Nuveenn Intermediate Duration Quality Municipal Term Fund's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.27% (day), 1.47% (last week), and 1.03% (last month), respectively.

Nuveenn Intermediate Duration Quality Municipal Term Fund's Stock Yearly Top and Bottom Value

Nuveenn Intermediate Duration Quality Municipal Term Fund's stock is valued at $14.85 at 19:23 EST, under its 52-week high of $15.70 and above its 52-week low of $14.18.

Nuveenn Intermediate Duration Quality Municipal Term Fund's Moving Average

Nuveenn Intermediate Duration Quality Municipal Term Fund's value is higher than its 50-day moving average of $14.73 and higher than its 200-day moving average of $14.82.

4. The Blackstone Group (BX)

41.32% Payout Ratio

The Blackstone Group Inc. is an alternative asset management firm specializing in real estate, private equity, hedge fund solutions, credit, secondary funds of funds, public debt and equity and multi-asset class strategies.

Volume

Today's last reported volume for The Blackstone Group is 2058930, 41.8% below its average volume of 3537780.

As claimed by Morningstar, Inc., the next dividend payment is on Jul 29, 2021, the estimated forward annual dividend rate is 3.02 and the estimated forward annual dividend yield is 2.67%.

The Blackstone Group's sales growth this year is anticipated to be 37.4% and 12.2% for next year.

Year-on-year quarterly revenue growth grew by 106.1%, now sitting on 17.33B for the twelve trailing months.

The Blackstone Group's sales growth is 37.7% for the current quarter and negative 13.1% for the next. The company's growth estimates for the present quarter and the next is 39.7% and negative -0.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 62.77%.

Volatility

The Blackstone Group's last day, week, and month's current volatility was 1.19%, 2.18%, and 1.92%, respectively.

The Blackstone Group's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.46% (day), 2.58% (last week), and 2.79% (last month), respectively.

The Blackstone Group's Stock Yearly Top and Bottom Value

The Blackstone Group's stock is valued at $142.80 at 19:23 EST, below its 52-week high of $146.80 and way higher than its 52-week low of $54.75.

The Blackstone Group's Moving Average

The Blackstone Group's value is way above its 50-day moving average of $128.40 and way higher than its 200-day moving average of $110.96.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com